Table 1. The distribution of the cell cycle phase after OPFR treatment.

Groups	Time dose	24 h			48 h
		G0/G1	S	G2/M	G0/G1	S	G2/M
	Control	61.5 ± 0.1	24.9 ± 0.2	13.6 ± 0.3	67.8 ± 1.2	19.4 ± 0.3	12.8 ± 0.4
TBP	50 μM	66.3 ± 0.1*	20.2 ± 0.9	13.5 ± 0.9	71.0 ± 0.5*	18.0 ± 0.1	11.0 ± 0.3
	100 μM	67.3 ± 0.9**	21.9 ± 1.1	10.8 ± 2.0	73.5 ± 1.0**	16.0 ± 1.0	10.5 ± 0.1
	200 μM	71.7 ± 0.1**	17.3 ± 0.5	11.0 ± 0.4	76.8 ± 0.1**	14.2 ± 0.7	9.0 ± 0.6
TBEP	50 μM	65.2 ± 0.1*	21.9 ± 0.7	12.9 ± 0.6	74.4 ± 0.8**	15.5 ± 0.7	10.1 ± 0.1
	100 μM	67.0 ± 1.1**	21.3 ± 1.0	11.7 ± 0.1	75.55 ± 0.4**	14.7 ± 0.1	9.8 ± 0.5
	200 μM	68.1 ± 0.8**	19.7 ± 0.1	12.2 ± 0.8	76.5 ± 0.5**	14.9 ± 1.3	8.6 ± 0.8